Pathway Blog

Featured Articles

Endoscopic view of normal versus two important GERD complications: erosive esophagitis and Barrett’s esophagus. The latter is associated with an increased risk of esophageal cancer.

July 15, 2022

Deep Dive: Gastroesophageal Reflux Disease (GERD) Diagnosis and Treatment

Get a succinct overview of the latest GERD diagnosis & treatment guidelines.

Dr. Louis Mullie, Co-Founder and Chief Medical Officer at Pathway, has co-authored an analysis paper in the British Medical Journal (BMJ) on the impact of artificial intelligence (AI) for bedside care during COVID-19 and future pandemics.

January 11, 2022

Pathway co-founder Dr. Louis Mullie co-authors BMJ analysis paper on AI in bedside care during COVID-19

Dr. Louis Mullie, Co-Founder and Chief Medical Officer at Pathway, has co-authored an analysis paper in the British Medical Journal (BMJ) on the impact of artificial intelligence (AI) for bedside care during COVID-19 and future pandemics.

Endoscopic view of normal versus two important GERD complications: erosive esophagitis and Barrett’s esophagus. The latter is associated with an increased risk of esophageal cancer.

July 15, 2022

Deep Dive: Gastroesophageal Reflux Disease (GERD) Diagnosis and Treatment

Dr. Louis Mullie, Co-Founder and Chief Medical Officer at Pathway, has co-authored an analysis paper in the British Medical Journal (BMJ) on the impact of artificial intelligence (AI) for bedside care during COVID-19 and future pandemics.

January 11, 2022

Pathway co-founder Dr. Louis Mullie co-authors BMJ analysis paper on AI in bedside care during COVID-19

Pathway Platform on Mobile and Tablet

October 14, 2021

Pathway Raises $1.6 Million to Scale its AI-Powered Medical Knowledge Platform

Newsletter

Subscribe below to stay up-to-date on the latest Pathway news.

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.